Trials / Completed
CompletedNCT07072572
Lung Point of Care Ultrasound to Guide Albumin Administration in Cirrhosis
Lung Point Of Care Ultrasond (L-Pocus)-Guided Administration Of Intravenous Albumin In Decompensated Cirrhosis: A Pilot, Open Label, Randomized Controlled Trial
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 72 (actual)
- Sponsor
- Centro Medico Issemym · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To guide the administration of intravenous albumin by lung ultrasound in decompensated cirrhosis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Lower albumin dosage | A fixed dose of 35 grams of albumin on they one and day two. |
Timeline
- Start date
- 2023-03-01
- Primary completion
- 2023-12-14
- Completion
- 2024-11-14
- First posted
- 2025-07-18
- Last updated
- 2025-07-18
Locations
1 site across 1 country: Mexico
Source: ClinicalTrials.gov record NCT07072572. Inclusion in this directory is not an endorsement.